Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Entresto (sacubitril/valsartan) Disease area(s): Cardiovascular Manufacturer(s): Novartis 2024 Sales (USD): $7.82 billion Why it sold so well: In 2024, Novartis heart failure medication, Entresto, had remarkable sales growth, generating $7.8 billion in revenue, a 31% increase over the previous year
Both can be applied at the time of your consultation
Whether youre thinking of opting for Ozempic or leaning towards Liraglutide, its important to discuss any potential change with your healthcare provider
Refrigeration is essential
US$ 23.82
US$ 27.59
US$ 21.14
US$ 21.71
US$ 26.56
